Company Filing History:
Years Active: 2022
Title: Isa Jana Irina Janssen: Innovator in Pharmaceutical Compounds
Introduction
Isa Jana Irina Janssen is a notable inventor based in Cologne, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating helminth infections. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Isa Jana Irina Janssen holds a patent for azaquinoline derivatives. The present invention covers azaquinoline compounds of general formula (I), with A being (A1) or (A2). In this patent, T, R, R, R, R, R, and Q are defined as specific components. The invention includes methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that incorporate these compounds. The use of these compounds is aimed at manufacturing pharmaceutical compositions for the treatment, control, and prevention of diseases, particularly helminth infections, either as a sole agent or in combination with other active ingredients.
Career Highlights
Isa Jana Irina Janssen is currently employed at Bayer Animal Health GmbH, where she continues to contribute to the field of veterinary medicine. Her work at Bayer has allowed her to collaborate with leading experts in the industry and to further her research in pharmaceutical innovations.
Collaborations
Some of her notable coworkers include Nils Griebenow and Wei Zhuang. Their collaborative efforts have enhanced the research and development processes within their projects.
Conclusion
Isa Jana Irina Janssen is a pioneering inventor whose work in azaquinoline derivatives has the potential to significantly impact the treatment of helminth infections. Her contributions to Bayer Animal Health GmbH and the pharmaceutical industry exemplify her commitment to innovation and improving health outcomes.